Identification of CD90 as Putative Cancer Stem Cell Marker and Therapeutic Target in Insulinomas

Floryne O. Buishand, Ger J. A. Arkesteijn, Laurien R. Feenstra, Claire W. D. Oorsprong, Margiet Mestemaker, Achim Starke, Ernst-Jan M. Speel, Jolle Kirpensteijn, Jan A. Mol

Research output: Contribution to journalArticleAcademicpeer-review

2 Citations (Scopus)
Original languageEnglish
Pages (from-to)826-835
JournalStem Cells and Development
Volume25
Issue number11
DOIs
Publication statusPublished - 1 Jun 2016

Cite this

Buishand, F. O., Arkesteijn, G. J. A., Feenstra, L. R., Oorsprong, C. W. D., Mestemaker, M., Starke, A., Speel, E-J. M., Kirpensteijn, J., & Mol, J. A. (2016). Identification of CD90 as Putative Cancer Stem Cell Marker and Therapeutic Target in Insulinomas. Stem Cells and Development, 25(11), 826-835. https://doi.org/10.1089/scd.2016.0032